nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A natural DNMT1 mutation elevates the fetal hemoglobin level via epigenetic derepression of the γ-globin gene in β-thalassemia
|
Gong, Yi |
|
|
137 |
12 |
p. 1652-1657 |
artikel |
2 |
A new era in the treatment of acute lymphoblastic leukemia
|
Jabbour, Elias |
|
|
137 |
12 |
p. 1563-1564 |
artikel |
3 |
A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)
|
Brivio, Erica |
|
|
137 |
12 |
p. 1582-1590 |
artikel |
4 |
Checkpoint inhibitors and thrombosis: what's up?
|
Beyer-Westendorf, Jan |
|
|
137 |
12 |
p. 1569-1570 |
artikel |
5 |
Early assessment of clofarabine effectiveness based on measurable residual disease, including AML stem cells
|
Hanekamp, Diana |
|
|
137 |
12 |
p. 1694-1697 |
artikel |
6 |
Editorial Board
|
|
|
|
137 |
12 |
p. i |
artikel |
7 |
β-Hemoglobinopathies lead the way
|
Saunthararajah, Yogen |
|
|
137 |
12 |
p. 1567-1569 |
artikel |
8 |
How should we use convalescent plasma therapies for the management of COVID-19?
|
Wood, Erica M. |
|
|
137 |
12 |
p. 1573-1581 |
artikel |
9 |
IKZF1 alterations predict poor prognosis in adult and pediatric T-ALL
|
Simonin, Mathieu |
|
|
137 |
12 |
p. 1690-1694 |
artikel |
10 |
Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy
|
Moik, Florian |
|
|
137 |
12 |
p. 1669-1678 |
artikel |
11 |
Minimal residual disease quantification in ovarian tissue collected from patients in complete remission of acute leukemia
|
Chevillon, Florian |
|
|
137 |
12 |
p. 1697-1701 |
artikel |
12 |
Modeling acute erythroid leukemia via CRISPR
|
Zhang, Jian-Ping |
|
|
137 |
12 |
p. 1565-1567 |
artikel |
13 |
Modeling and targeting of erythroleukemia by hematopoietic genome editing
|
Iacobucci, Ilaria |
|
|
137 |
12 |
p. 1628-1640 |
artikel |
14 |
Multiple Auer rods in a mixed-phenotype acute leukemia
|
Chang, Hong |
|
|
137 |
12 |
p. 1702 |
artikel |
15 |
MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis
|
Yu, Xinfang |
|
|
137 |
12 |
p. 1615-1627 |
artikel |
16 |
piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL
|
Han, Huiying |
|
|
137 |
12 |
p. 1603-1614 |
artikel |
17 |
Quicker and digital: the way on protein biomarkers?
|
Calin, George A. |
|
|
137 |
12 |
p. 1564-1565 |
artikel |
18 |
Rapid single-molecule digital detection of protein biomarkers for continuous monitoring of systemic immune disorders
|
Song, Yujing |
|
|
137 |
12 |
p. 1591-1602 |
artikel |
19 |
Secreted modular calcium-binding protein 1 binds and activates thrombin to account for platelet hyperreactivity in diabetes
|
Delgado Lagos, Fredy |
|
|
137 |
12 |
p. 1641-1651 |
artikel |
20 |
The metabolic enzyme pyruvate kinase M2 regulates platelet function and arterial thrombosis
|
Nayak, Manasa K. |
|
|
137 |
12 |
p. 1658-1668 |
artikel |
21 |
The pulmonary metatranscriptome prior to pediatric HCT identifies post-HCT lung injury
|
Zinter, Matt S. |
|
|
137 |
12 |
p. 1679-1689 |
artikel |
22 |
Unraveling the lung metatranscriptome in HCT
|
Waghmare, Alpana |
|
|
137 |
12 |
p. 1570-1572 |
artikel |